By representing equities in multi sectors we offset investor risk no different than the approach we would take in our own investment portfolios. Brisco acts on a referral basis, all clients are scrutinized through layers of due diligence by capital market members in order to protect the investment community we represent. The system is not perfect by any means but every precaution is needed to avoid investment losses in today’s volatile market.
Namaste Technologies Inc. uses advanced analytics to consistently outperform all competition on a day to day basis. In February 2017, they advanced further with the deployment of their new websites. They continue to strive towards technological innovation in the vaporizer market and are now developing advanced learning strategies and thorough education throughout their web properties and in their back office.
Namaste is a global leader in vaporizer product distribution and manufacturing. They own and operate over 30 online retail sites in over 20 countries worldwide. They are also active in the business of product development and manufacturing. Namaste is on pace to become the largest e-commerce distributor of vaporizers and accessories in the world.
To learn more about Namaste Technologies Inc. visit their website http://www.namastetechnologies.com/
Founded by entrepreneurs with decades of experience in investment banking, corporate finance, law and healthcare services, iAnthus Capital Holdings Inc. provides a unique combination of capital and hands-on operating and management expertise.
iAnthus provides investors diversified exposure to best-in-class licensed cannabis cultivators, processors and dispensaries throughout the United States.The Company leverages these skills to support a diversified portfolio of cannabis industry investments for our shareholders.
To learn more about iAnthus Capital Holdings, visit About iAnthus Capital
Trenchant Capital is an investment issuer that has formed a strategic alliance with one of the largest private equity firms in Canada. read more…
Immunovaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases.